Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-23

Clinical Trial Update: Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the long-term growth and skeletal effects of early growth hormone treatment in girls with Turner syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUMATROPE (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Turner Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2016-08-23